SCHEMBL1472630

SCHEMBL1472630

C=CC(C)(CC/C=C(\C)CC)OC(C)=O

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.38
GAA P10253 1/20 0.36
HIF1A Q16665 2/20 0.35
EPAS1 Q99814 2/20 0.35
TRPC6 Q9Y210 1/20 0.33
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628421 1.00 ALOX15 (0.38) ALOX15GAAHIF1AEPAS1TRPC6
SCHEMBL29619766 1.00 ALOX15 (0.38) ALOX15GAAHIF1AEPAS1TRPC6
SCHEMBL31412795 1.00 ALOX15 (0.38) ALOX15GAAHIF1AEPAS1TRPC6
SCHEMBL1472631 1.00 ALOX15 (0.38) ALOX15GAAHIF1AEPAS1TRPC6
SCHEMBL16461955 0.89 ALOX15 (0.42) ALOX15GAAHIF1AEPAS1TRPC6
SCHEMBL16461953 0.89 ALOX15 (0.42) ALOX15GAAHIF1AEPAS1TRPC6
SCHEMBL10977628 0.89 BTN3A1 (0.38) ALOX15GAAHIF1AEPAS1TRPC6
SCHEMBL10977620 0.89 BTN3A1 (0.38) ALOX15GAAHIF1AEPAS1TRPC6
Linalyl Acetate SCHEMBL15745424 0.86 ALOX15 (0.52) ALOX15GAAHIF1AEPAS1TRPC6
Linalyl Acetate SCHEMBL58028 0.86 ALOX15 (0.52) ALOX15GAAHIF1AEPAS1TRPC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230404887-A1 COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF SWEAT MALODOR FIRMENICH SA (CH) 2023-12-21 US claimed
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2026-04-09 US disclosed
US-12577511-B2 Agent containing emulsifier and microcapsules HENKEL AG & CO. KGAA (DE) 2026-03-17 US disclosed
US-12508218-B2 Coating compositions COTY INC. (US) 2025-12-30 US disclosed
EP-4489592-B1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2025-12-24 EP disclosed
EP-3103523-B1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION PROCTER & GAMBLE (US) 2025-10-29 EP disclosed
US-20250255827-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-08-14 US disclosed
US-20250186960-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-06-12 US disclosed
EP-3888782-B1 COATED MICROCAPSULES NOXELL CORP (US) 2025-06-11 EP disclosed
US-20250177298-A1 EMULSIONS AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-06-05 US disclosed
EP-2907568-A1 A FRAGRANCE-DELIVERY COMPOSITION COMPRISING PERSULFATE ION-CROSSLINKED POLYVINYL ALCOHOL MICROCAPSULES AND METHOD OF USE THEREOF APPVION, INC. (US) 2015-08-19 EP disclosed
US-20140221269-A1 OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2014-08-07 US disclosed
US-8754028-B2 Perfume systems THE PROCTER & GAMBLE COMPANY (US) 2014-06-17 US disclosed
US-7915215-B2 Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof APPLETON PAPERS INC. (US) 2011-03-29 US disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed
US-20100152083-A1 Perfume Systems PROCTER & GAMBLE COMPANY, THE 2010-06-17 US disclosed
US-20100099594-A1 Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof IPS ADHESIVES LLC 2010-04-22 US disclosed
US-20080176781-A1 Perfumes for linear citrus release in rinse-off systems QUEST INTERNATIONAL SERVICES B.V. (NL) 2008-07-24 US disclosed
EP-0131254-B1 PROCESS FOR THE PREPARATION OF SUBSTITUTED TETRAHYDROFURANES L. GIVAUDAN & CIE Société Anonyme (CH) 1988-05-25 EP disclosed
EP-0131254-A2 Process for the preparation of substituted tetrahydrofuranes L. GIVAUDAN & CIE Société Anonyme (CH) 1985-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION PCTP, CLK4, MTCL3 ALOX15 4169/4885GAA 2863/4885HIF1A 1638/4885
US-12577511-B2 Agent containing emulsifier and microcapsules LIPA, CUTA, MGLL ALOX15 311/4885GAA 1306/4885HIF1A 1864/4885
US-12508218-B2 Coating compositions TAS2R40, TAS2R20, TAS2R10 ALOX15 3918/4885GAA 1364/4885HIF1A 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.